NLK Antibody [D1D21] | Primary Antibodies

Application: Reactivity: Human, Mouse, Rat

Usage Information

Dilution
WB1:1000

Application
WB

Reactivity
Human, Mouse, Rat

Source
Rabbit Monoclonal Antibody

Storage Buffer
PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3

Storage (from the date of receipt)
-20°C (avoid freeze-thaw cycles), 2 years

Predicted MW
58 kDa

Datasheet & SDS

Biological Description

Specificity
NLK Antibody [D1D21] detects endogenous levels of total NLK protein.

Clone
D1D21

Synonym(s)
DKFZp761G1211, FLJ21033, LAK1, nemo like kinase, Nemo-like kinase, NLK, Protein LAK1, Serine/threonine-protein kinase NLK

Background
Nemo‑like kinase (NLK) is an evolutionarily conserved serine/threonine protein kinase related to the MAP kinase family that is expressed at high levels in neural tissues and participates in multiple signaling pathways controlling cell fate and tissue homeostasis. The kinase domain shows features of an atypical proline‑directed kinase, and NLK activity depends on autoregulatory mechanisms and protein–protein interactions that support homodimer formation and nuclear localization described for vertebrate NLK orthologs. NLK integrates input from Wnt/β‑catenin signaling by phosphorylating TCF/LEF family transcription factors and other Wnt pathway components, which alters their transcriptional activity and reduces β‑catenin–dependent target gene expression in several systems. NLK also responds to ligands such as IL‑6, TGF‑β, and non‑canonical Wnt ligands, and through these routes connects to additional pathways including JAK/STAT‑linked inflammation and Smad‑dependent growth factor signaling, placing NLK at a convergence point for extracellular cues that regulate proliferation, differentiation, migration, and apoptosis. The kinase phosphorylates a range of transcriptional regulators beyond TCF/LEF, including factors such as c‑Myb, FOXO proteins, and co‑regulators like HDAC1, and these modifications influence DNA binding, cofactor recruitment, or chromatin association of the substrates and thereby modulate gene expression programs related to cell cycle control and stress responses. NLK expression and functional activity are prominent during vertebrate embryogenesis and nervous system development, where NLK family members participate in patterning of anterior neural structures, regulation of neuronal differentiation, and coordination of Wnt and Notch pathway outputs in neural progenitors. Across cancer types, NLK expression shows context‑dependent changes and associates with altered cell proliferation, migration, invasion, or apoptosis, with reports of NLK acting as a negative regulator of Wnt/β‑catenin–driven growth in some tumors and as a positive regulator of oncogenic transcriptional programs in others. NLK is detected in both nuclear and cytoplasmic compartments, and its subcellular distribution, interaction partners, and kinase activity define which transcriptional circuits or signaling branches are affected in a given cell type, making NLK a multifunctional node that links extracellular signaling inputs to transcription factor phosphorylation and downstream functional outcomes in development and disease.

Background

Nemo‑like kinase (NLK) is an evolutionarily conserved serine/threonine protein kinase related to the MAP kinase family that is expressed at high levels in neural tissues and participates in multiple signaling pathways controlling cell fate and tissue homeostasis. The kinase domain shows features of an atypical proline‑directed kinase, and NLK activity depends on autoregulatory mechanisms and protein–protein interactions that support homodimer formation and nuclear localization described for vertebrate NLK orthologs. NLK integrates input from Wnt/β‑catenin signaling by phosphorylating TCF/LEF family transcription factors and other Wnt pathway components, which alters their transcriptional activity and reduces β‑catenin–dependent target gene expression in several systems. NLK also responds to ligands such as IL‑6, TGF‑β, and non‑canonical Wnt ligands, and through these routes connects to additional pathways including JAK/STAT‑linked inflammation and Smad‑dependent growth factor signaling, placing NLK at a convergence point for extracellular cues that regulate proliferation, differentiation, migration, and apoptosis. The kinase phosphorylates a range of transcriptional regulators beyond TCF/LEF, including factors such as c‑Myb, FOXO proteins, and co‑regulators like HDAC1, and these modifications influence DNA binding, cofactor recruitment, or chromatin association of the substrates and thereby modulate gene expression programs related to cell cycle control and stress responses. NLK expression and functional activity are prominent during vertebrate embryogenesis and nervous system development, where NLK family members participate in patterning of anterior neural structures, regulation of neuronal differentiation, and coordination of Wnt and Notch pathway outputs in neural progenitors. Across cancer types, NLK expression shows context‑dependent changes and associates with altered cell proliferation, migration, invasion, or apoptosis, with reports of NLK acting as a negative regulator of Wnt/β‑catenin–driven growth in some tumors and as a positive regulator of oncogenic transcriptional programs in others. NLK is detected in both nuclear and cytoplasmic compartments, and its subcellular distribution, interaction partners, and kinase activity define which transcriptional circuits or signaling branches are affected in a given cell type, making NLK a multifunctional node that links extracellular signaling inputs to transcription factor phosphorylation and downstream functional outcomes in development and disease.

References
https://pubmed.ncbi.nlm.nih.gov/26427665/ https://pubmed.ncbi.nlm.nih.gov/23000342/

Reference Table for Selecting PVDF Membrane Pore Size Specifications

Protein Size (kDa)	PVDF Transfer Membrane Pore Size (μm)
< 10	0.22
10-20	0.22
20-30	0.45
30-45	0.45
45-70	0.45
80-100	0.45
100-140	0.45
> 140	0.45

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Protein Size (kDa)	Separating Gel Percentage
4-40	20%
12-45	15%
10-70	12.5%
15-100	10%
25-100	8%
60-210	5%